1. To summarize the current standard of care for patients with malignant glioma.
  2. To review the history of and reasoning behind treatments for malignant glioma.
  3. To discuss Optune-TTF, a new treatment modality for patients with malignant glioma
Session date: 
08/25/2017 - 3:00pm to 4:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Scott Turner MD